Hot Debate: Complement Inhibition vs Nefecon in IgA Nephropathy – Which First for Patients at Risk?
30 Mar 2026 14:10 15:10
501 - 502
| Time | Session |
|---|
|
14:10
15:10
|
Complement Inhibition Should Be Considered Before Nefecon in Patients With IgAN at Risk of Progression
|
Nefecon Should Be Considered Before Complement Inhibition in Patients With IgAN at Risk of Progression
|